Value Added Tax Hidden in Health Reform

By: Theodore Kettle
Saturday, November 28, 2009

With spending at nearly 25 percent of GDP and headed for more than 40 percent of national output, according to the liberal Progressive Policy Institute, how will the Democrats pay for it all?

The evidence points toward the way big-government, slow-growth Europe does it: the value added tax.

Working as a sales tax that you don’t get to see on your receipt, the VAT has proven to be a brutally efficient money machine in other countries. Maybe that’s why Speaker of the House Nancy Pelosi last month told Charlie Rose that a VAT was “on the table” as a solution to America’s fiscal liabilities.

But it’s not just “on the table.” It’s in the Senate’s health reform bill soon to be voted on.

The Senate bill’s “fee” on medical devices operates much like a VAT, and could end up being the model for future adoption of an unprecedented VAT on all goods and services in the United States.

Deep into the 2,074-page bill, on page 2,020, is “SEC. 9009,” the “Imposition of Annual Fee on Medical Device Manufacturers and Importers.” It orders that “Each covered entity engaged in the business of manufacturing or importing medical devices shall pay to the [Treasury] Secretary not later than the annual payment date of each calendar year beginning after 2009 a fee in an amount determined under subsection (b).”

The amount of tax would be based on “gross receipts from medical device sales.” Treasury bureaucrats would have the formidable power of “identification of medical devices” and the new tax would be retroactive, applying to “any medical device sales after December 31, 2008.”

This article continues at

Comments are closed.